| 英文名称 |
中文名称 |
CAS号 |
操作 |
| MAX-40279 hemifumarate |
化合物 MAX-40279 HEMIFUMARATE |
2388506-43-0 |
详细
|
| Nintedanib esylate |
尼达尼布乙磺酸盐 |
656247-18-6 |
详细
|
| 4SC-203 |
4SC-203 |
895533-09-2 |
详细
|
| KHS101 hydrochloride |
盐酸KHS101 |
1784282-12-7 |
详细
|
| AP1867-3-(aminoethoxy) |
AP1867-3-(Methoxyethylamine) |
2127390-15-0 |
详细
|
| DSHS00884 |
DSHS00884 |
675104-49-1 |
详细
|
| Derazantinib Racemate |
化合物 T10997 |
2309668-44-6 |
详细
|
| UNC2025 hydrochloride |
UNC2025 盐酸盐 |
2070015-17-5 |
详细
|
| Quiflapon sodium |
喹夫拉朋钠 |
147030-01-1 |
详细
|
| GPR40 Activator 2 |
化合物 T11457 |
1312787-30-6 |
详细
|
| Zoligratinib |
DEBIO-1347 |
1265229-25-1 |
详细
|
| FIIN-2 |
FIIN-2 |
1633044-56-0 |
详细
|
| FIIN-3 |
FIIN-3 |
1637735-84-2 |
详细
|
| AM-4668 |
AM-4668 |
1011531-27-3 |
详细
|
| FB23 |
FB23 |
2243736-35-6 |
详细
|
| GPR40/FFAR1 modulator 1 |
GPR40/FFAR1 modulator 1 |
874755-26-7 |
详细
|
| MAX-40279 hemiadipate |
化合物 MAX-40279 HEMIADIPATE |
2388506-44-1 |
详细
|
| AG-09/1 |
2-[(6-methoxy-1H-benzimidazol-2-yl)thio]-N-(4-nitrophenyl)-acetamide |
356776-32-4 |
详细
|
| NSC12 |
CS-2161 |
102586-30-1 |
详细
|
| Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
详细
|
| SAFit1 |
SAFit1 |
1643125-32-9 |
详细
|
| ODM-203 |
ODM203 |
1430723-35-5 |
详细
|
| E7090 succinate |
化合物 E7090 SUCCINATE |
1879965-80-6 |
详细
|
| FLT3-IN-3 |
SAN50900 |
2229050-90-0 |
详细
|
| Vonafexor |
YP001 |
1192171-69-9 |
详细
|
| FGFR1/DDR2 inhibitor 1 |
FGFR1/DDR2 inhibitor 1 |
2308497-58-5 |
详细
|
| FGFR-IN-1 |
|
1513860-41-7 |
详细
|
| Fostamatinib Disodium |
R788(FOSTAMATINIB DISODIUM) |
1025687-58-4 |
详细
|
| PP58 |
Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl- |
212391-58-7 |
详细
|
| JK-P3 |
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 |
942655-44-9 |
详细
|
| ASP5878 |
ASP-5878 |
1453208-66-6 |
详细
|
| AP1867 |
AP1867 |
195514-23-9 |
详细
|
| EBOV/MARV-IN-1 |
VUN65671 |
2479465-67-1 |
详细
|
| PD-166866 |
PD-166866 |
192705-79-6 |
详细
|
| TG 100572 Hydrochloride |
4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚单盐酸盐 |
867331-64-4 |
详细
|
| TUG-770 |
TUG-770 |
1402601-82-4 |
详细
|
| FPR Agonist 43 |
1-(4-氯苯基)-3-(5-异丙基-1-甲基-3-氧亚基-2-苯基-2,3-二氢-1H-吡唑-4-基)脲 |
903895-98-7 |
详细
|
| AP1867-2-(carboxymethoxy) |
FKBP12 LIGAND |
2230613-03-1 |
详细
|
| BO-264 |
BO-264 |
2408648-20-2 |
详细
|
| BMS-986235 |
BMS-986235 |
2253947-47-4 |
详细
|
| HM43239 |
化合物HM43239 |
2294874-49-8 |
详细
|
| OTS447 |
化合物 OTS447 |
1356943-67-3 |
详细
|
| SU4984 |
CIVENTICHEM CV-409 |
186610-89-9 |
详细
|
| Fostamatinib |
福他替尼 |
901119-35-5 |
详细
|
| TAK-875 |
TAK-875 |
1000413-72-8 |
详细
|
| Ponatinib hydrochloride |
泊那替尼盐酸盐 |
1114544-31-8 |
详细
|
| CP-547632 hydrochloride |
CP-547632 (hydrochloride) |
252003-71-7 |
详细
|
| Gilteritinib hemifumarate |
GILTERITINIB FUMARATE |
1254053-84-3 |
详细
|
| Fisogatinib |
BLU554 |
1707289-21-1 |
详细
|
| S49076 |
CS-2684 |
1265965-22-7 |
详细
|
| E7090 |
E-7090 |
1622204-21-0 |
详细
|
| TUG-469 |
TUG-469 |
1236109-67-3 |
详细
|
| Fezagepras sodium |
1254472-97-3 |
1254472-97-3 |
详细
|
| GPR120 Agonist 2 |
3-(4-((5-氯-2,2-二甲基-2,3-二氢苯并呋喃-7-基)甲氧基)-2,3-二甲基苯基)丙酸 |
1234844-11-1 |
详细
|
| Shield-1 |
化合物SHIELD-1 |
914805-33-7 |
详细
|
| Pemigatinib |
培米加替尼 |
1513857-77-6 |
详细
|
| HCH6-1 |
D-Phenylalanine, N-benzoyl-L-tryptophyl-, methyl ester |
1435265-06-7 |
详细
|
| FLT3-IN-6 |
FLT3-IN-6 |
2377141-31-4 |
详细
|
| FKBP12 PROTAC dTAG-13 |
FKBP12 PROTAC DTAG-13 |
2064175-41-1 |
详细
|
| 2'-Deoxy-5'-O-DMT-2'-fluorouridine |
5'-O-[双(4-甲氧基苯基)(苯基)甲基]-2'-脱氧-2'-氟尿苷 |
146954-74-7 |
详细
|
| {Boc}-Phe-Leu-Phe-Leu-Phe |
BOC-PHE-D-LEU-PHE-D-LEU-PHE-OH |
66556-73-8 |
详细
|
| R1530 |
5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓 |
882531-87-5 |
详细
|
| ASN03576800 |
ASN03576800 |
957513-35-8 |
详细
|
| AH 7614 |
AH 7614 |
6326-06-3 |
详细
|
| Derazantinib |
德拉赞替尼 |
1234356-69-4 |
详细
|
| FGFR4-IN-1 |
CS-2343 |
1708971-72-5 |
详细
|
| TAK-659 hydrochloride |
TAK-659 (HYDROCHLORIDE) |
1952251-28-3 |
详细
|
| TUG-1375 |
(2R,4R)-2-(2-氯苯基)-3-(4-(3,5-二甲基异恶唑-4-基)苯甲酰)噻唑烷-4-甲酸 |
2247372-59-2 |
详细
|
| FKBP12 PROTAC dTAG-7 |
FKBP12 PROTAC DTAG-7 |
2064175-32-0 |
详细
|
| Bemarituzumab |
贝马里妥珠单抗 |
1952272-74-0 |
详细
|
| Diflapolin |
双黄素 |
724453-98-9 |
详细
|
| KW-2449 |
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 |
1000669-72-6 |
详细
|
| Vidofludimus |
维多氟拉迪莫 |
717824-30-1 |
详细
|
| DY268 |
DY 268 |
1609564-75-1 |
详细
|
| MRX-2843 |
UNC-2371A |
1429882-07-4 |
详细
|
| Tropifexor |
Tropifexor |
1383816-29-2 |
详细
|
| PX20606 trans racemate |
CPDD1220反式消旋体 |
1268244-85-4 |
详细
|
| KB02-SLF |
KB02-SLF |
2384184-40-9 |
详细
|
| Surfen dihydrochloride |
1,3-bis(4-amino-2-methyl-6-quinolyl)urea dihydrochloride |
5424-37-3 |
详细
|
| Gunagratinib |
GUNAGRATINIB |
2211082-53-8 |
详细
|
| CP-547632 |
3-[(4-溴-2,6-二氟苄基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]异噻唑-4-甲酰胺 |
252003-65-9 |
详细
|
| TG101209 |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
详细
|
| Pacritinib |
帕克替尼 |
937272-79-2 |
详细
|
| SSR128129E |
SSR128129E |
848318-25-2 |
详细
|
| Gilteritinib |
吉列替尼 |
1254053-43-4 |
详细
|
| Tyrosine kinase-IN-1 |
TYROSINE KINASE-IN-1 |
705946-27-6 |
详细
|
| BLU9931 |
BLU 9931 |
1538604-68-0 |
详细
|
| LY2562175 |
化合物LY2562175 |
1103500-20-4 |
详细
|
| Emavusertib |
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- |
1801344-14-8 |
详细
|
| SLF TFA |
|
2378802-47-0 |
详细
|
| (Z)-Orantinib |
SU 6668 |
210644-62-5 |
详细
|
| AMG7703 |
(S)-2-(4-chlorophenyl)-3-Methyl-N-(thiazol-2-yl)butanaMide |
1103523-24-5 |
详细
|
| AM103 |
AM 103 |
1147872-22-7 |
详细
|
| ATH686 |
化合物ATH 686 |
853299-52-2 |
详细
|
| AM-1638 |
化合物 T14200 |
1142214-62-7 |
详细
|
| LY2922470 |
LY2922470 |
1423018-12-5 |
详细
|
| PROTAC FLT-3 degrader 1 |
PROTAC FLT-3 DEGRADER 1 |
2230826-81-8 |
详细
|
| SLF-amido-C2-COOH |
SLF-amido-C2-COOH |
1092369-24-8 |
详细
|
| GPR40 agonist 6 |
化合物 GPR40 AGONIST 6 |
1798751-25-3 |
详细
|
| CPL304110 |
化合物 CPL304110 |
1627826-19-0 |
详细
|